Hippo-Mediated Suppression of IRS2/AKT Signaling Prevents Hepatic Steatosis and Liver Cancer

Journal of Clinical Investigation - United States
doi 10.1172/jci95802
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Suppression of PPARγ-mediated Monoacylglycerol O-Acyltransferase 1 Expression Ameliorates Alcoholic Hepatic Steatosis

Scientific Reports
Multidisciplinary
2016English

Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Analytic Hepatic Deterioration in Rectal Cancer: Liver Steatosis vs Disease Progression

American Journal of Biomedical Science & Research
2019English

Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Axis Activates Akt Signaling to Ameliorate Hepatic Steatosis

Scientific Reports
Multidisciplinary
2016English

UNBS5162 Inhibits Colon Cancer Growth via Suppression of PI3K/Akt Signaling Pathway

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

IRE1α Prevents Hepatic Steatosis by Processing and Promoting the Degradation of Select microRNAs

Science Signaling
BiochemistryCell BiologyMolecular Biology
2018English

A Functional Interaction Between Hippo-Yap Signalling and SREBPs Mediates Hepatic Steatosis in Diabetic Mice

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Sphingomyelin Synthase 2 Activity and Liver Steatosis: An Effect of Ceramide-Mediated Peroxisome Proliferator-Activated Receptor 2 Suppression

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2013English

MAF1 Suppresses AKT-mTOR Signaling and Liver Cancer Through Activation of PTEN Transcription

Hepatology
MedicineHepatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy